Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : PFE (Pfizer) How high will it go? -- Ignore unavailable to you. Want to Upgrade?

To: BigKNY3 who wrote (6864)	1/29/1999 8:24:00 AM
From: Jan P	Respond to of 9523

Selectus seeks to patent Viagra companion drug January 28, 1999 11:49 PM WEST CONSHOHOCKEN, Pa., Jan 28 (Reuters) - Selectus Pharmaceuticals said Thursday it had filed a U.S. patent application covering the use of esprolol plus Viagra to allow persons with heart disease to use the popular Pfizer PFE anti-impotence drug. Privately held Selectus, a development-stage company started in early 1997, said esprolol is a potent, fast-acting beta-blocker that lessens heart rates and blood pressure during physical exertion. To date a number of deaths have been reported allegedly in connection with the use of the anti-impotence drug. Cardiac implications were indicated in some of the deaths, though the U.S. Food and Drug Administration has said there is no proof that Viagra itself caused the deaths. Esprolol is currently undergoing Phase II clinical trials, Selectus said, and the drug was

To: BigKNY3 who wrote (6864)	1/29/1999 8:29:00 AM
From: Anthony Wong	Respond to of 9523

Man Arrested in Viagra Theft dailynews.yahoo.com

To: BigKNY3 who wrote (6864)	1/29/1999 8:34:00 AM
From: Anthony Wong	Read Replies (1) \| Respond to of 9523

Novartis tops managed care drug co. list Friday January 29, 12:35 am Eastern Time NEWTOWN, Pa., Jan 28 (Reuters) - Swiss pharmaceutical Novartis AG again topped the list of drug makers that managed care executives said best met their overall needs, according to Scott-Levin's Fall 1998 Managed Care Pharmacy Executive Promotional Audit. Novartis topped the list in all four rankings since it first appeared in the audit in the spring of 1997, according to a statement released Tuesday by Scott-Levin, a division of consulting services firm PMSI/Scott-Levin Inc. Novartis was recognized for its professional representatives, good product line, strong contracting, and overall support and understanding of the managed care industry. Novartis' overall net score actually dropped 15 percent, from 66 in spring 1998 to 56 in fall 1998. However, this score was still 44 percent higher than that of second-place Hoechst Marion Roussel, the unit of German Hoescht AG. Hoechst Marion Roussel saw a 15-percent increase in its overall net score, keeping its second-place ranking in the fall. HMR improved its rankings in the areas of contracts, value-added services and knowledgeable reps. SmithKline Beecham improved its overall ranking by two places, moving up to third in the fall 1998 audit. SB also improved its ranking in the other three assessment areas: contracting, value-added services and knowledgeable representatives. Zeneca remained steady at fourth place in fall 1998, but dropped in contracting, from second to sixth, and in knowledgeable representatives, from sixth to 13th. Warner-Lambert and Glaxo Wellcome tied for fifth overall, and Pfizer jumped back into the top 10, tying with Merck & Co. for seventh. Pfizer improved its overall net score by 80 percent. biz.yahoo.com

To: BigKNY3 who wrote (6864)	1/29/1999 6:22:00 PM
From: Anthony Wong	Read Replies (1) \| Respond to of 9523

01/29 11:55 Pakistan allows sale of anti-impotence drug Viagra ISLAMABAD, Jan 29 (Reuters) - Pakistani authorities have allowed the anti-impotence drug Viagra to be marketed in the country, the official APP news agency reported on Friday. It said the Ministry of Health had given final approval to the registration of the wonder drug after initial objections from its Medical Registration Board to a request from the makers of the drug, Pfizer Inc <PFE.N>. "The multinational pharmaceutical company Pfizer has been accorded the rights to market the drug in Pakistan," APP said. It quoted a company spokesman as saying: "We foresee a big boost in our sales with the launching of Viagra in Pakistani markets." He said the company would price the drug reasonably so it was available to all income groups in Pakistan. moneynet.com@NEWS-P2&Index=0&HeadlineURL=../News/NewsHeadlines.asp&DISABLE_FORM=&NAVSVC=News\Company